Nations that consume a lot of milk... also win a lot of Nobel prizes

Nations that consume a lot of milk and milk products also tend to have a lot of Nobel laureates among their populations, suggest the authors of a letter, published in Practical Neurology. Research published last year in the New England Journal of Medicine reported a strong association between a nation's chocolate consumption and Nobel laureate prowess, speculating that the flavonoid content of chocolate was behind the boost in brain power.

This got the letter authors thinking. As chocolate is often combined with milk, could it be the amount of milk/milk products consumed per head that fuels Nobel Prize success?

They looked at the 2007 data from the Food and Agriculture Organization on per capita milk consumption in 22 countries as well as the information provided by the author of the chocolate theory, and found a significant association.

Sweden has the most Nobel laureates per 10 million of its population (33). Although, it hosts the Nobel committee, which some might argue could introduce an element of bias; it also consumes the most milk per head of the population, getting through 340kg every year.

And Switzerland, which knocks back 300kg of the white stuff every year, has a Nobel haul of similar proportions (32).

At the other end of the scale, China has the lowest number of Nobel laureates in its population. But it also has the lowest milk consumption of the countries studied—at around 25kg a year.

There does seem to be a ceiling effect, however, note the authors, with no discernible impact beyond an annual per capita consumption of 350kg, as Finland's Nobel haul seems to attest.

Is milk consumption therefore simply a reflection of a strong educational system, or do Nobel Prize winners celebrate by drinking it, query the authors?

But there is a plausible biological explanation for the link: milk is rich in vitamin D, and this may boost brain power, the evidence suggests.

"So to improve your chances of winning Nobel prizes you should not only eat more chocolate but perhaps drink milk too: or strive for synergy with hot chocolate," conclude the authors, who highlight their conflicts of interest, which include a tendency to take milk with cereal and coffee, and to eat chocolate whenever the opportunity arises.

Milk, chocolate, and Nobel prizes Pract Neurol 2013;13: 63 doi 10.1136/practneurol-2012-000471

Most Popular Now

FDA approves first biosimilar for the treatment of…

The U.S. Food and Drug Administration today approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvas...

Merck set to join forces with Project Data Sphere …

Merck, a leading science and technology company has announced that it will enter into a strategic collaboration with Project Data Sphere LLC, an independent, not-for-prof...

FDA approval brings first gene therapy to the Unit…

The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treat...

Novartis appoints Bertrand Bodson as Chief Digital…

Novartis announced today that Bertrand Bodson, Chief Digital and Marketing Officer for Sainsbury's Argos, has been appointed to the new role of Chief Digital Officer, rep...

Boehringer Ingelheim Pharmaceuticals, Inc. receive…

Boehringer Ingelheim Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) approved CyltezoTM, a biosimilar to Humira®*, in a pre-filled sy...

Asthma medicine halves risk of Parkinson's

Parkinson's disease is a chronic disease with unknown causes. The disease destroys the brain cells that control body movements. Shivering, stiff arms and legs and poor co...

This is how belly fat could increase your cancer r…

It's been well established that obesity is a contributor to cancer risk, but how it actually causes cancer is still a question that hasn't been fully explained. A new Mic...

Sanofi and Regeneron announce that cemiplimab (REG…

Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation status to cemipli...

Tezepelumab significantly reduced asthma exacerbat…

AstraZeneca and Amgen Inc. (Amgen) announce results from the PATHWAY Phase IIb trial of tezepelumab that showed a significant reduction in the annual asthma exacerbation ...

Boehringer Ingelheim initiates Phase IIa study of …

Boehringer Ingelheim and pharmaceutical company Pharmaxis (ASX: PXS) announce that Boehringer Ingelheim has initiated a European and North American Phase IIa trial in NAS...

Extended treatment with Brilinta reduces risk of c…

AstraZeneca today announced results from a new sub-analysis of data from the Phase III PEGASUS-TIMI 54 trial demonstrating a 29% risk reduction in CV death (p=0.0041) fro...

Victoza® reduces the risk of major cardiovascular …

A new analysis of the landmark LEADER trial shows that Victoza® (liraglutide) reduced the risk of major cardiovascular (CV) events in people with type 2 diabetes at high ...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]